Leadiant Biosciences is a research-based pharmaceutical company dedicated to developing and distributing novel and effective therapies to meet the needs of patients. We focus on rare diseases and strive to provide excellence and innovation in our products and services. With a strong commitment to patient care, we put the patient first in everything we do.

Our product portfolio includes medications such as Abelcet ® (amphotericin B lipid complex injection), Carnitor ® (levocarnitine), Cystaran ® (cysteamine ophthalmic solution) 0. 44%, and Matulane ® (procarbazine hydrochloride). These therapies are designed to address specific rare disease conditions and improve patients' quality of life.

In addition to our drug development efforts, we value the role of patients and caregivers in research and drug development. We believe that their voice, experiences, and insights are crucial in understanding rare and ultra-rare diseases better, and we encourage their active participation. At Leadiant Biosciences, we are united by rare dedication and a unique culture where every employee contributes, and every patient matters.

Join us in our mission to make a difference in the lives of patients affected by rare diseases